Display options
Share it on

ACS Med Chem Lett. 2011 Jan 13;2(1):73-78. doi: 10.1021/ml100219d.

Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell.

ACS medicinal chemistry letters

Hua-Yu Leo Wang, Wenjun Xin, Maoquan Zhou, Todd A Stueckle, Yon Rojanasakul, George A O'Doherty

Affiliations

  1. Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, 02115.

PMID: 21643465 PMCID: PMC3105780 DOI: 10.1021/ml100219d

Abstract

A stereochemically diverse array of monosaccharide analogues of the trisaccharide based cardiac glycoside natural product digitoxin has been synthesized using a de novo asymmetric approach. The analogues were tested for cytotoxicity against the NCI panel of 60 human cancer cell lines and in more detail against non-small cell human lung cancer cells (NCI-H460). The results were compared with digitoxin and its aglycone digitoxigenin. Three novel digitoxin monosaccharide analogues with β-d-digitoxose, α-l-rhamnose, and α-l-amicetose sugar moieties showed excellent selectivity and activity. Further investigation revealed that digitoxin α-l-rhamnose and α-l-amicetose analogues displayed similar anti-proliferation effects, but with at least 5-fold greater potency in apoptosis induction than digitoxin against NCI-H460. This study demonstrates the ability to improve the digitoxin anti-cancer activity by modification of the stereochemistry and substitution of the carbohydrate moiety of this known cardiac drug.

References

  1. Org Lett. 2005 Sep 1;7(18):3921-4 - PubMed
  2. Org Lett. 2006 Sep 14;8(19):4339-42 - PubMed
  3. J Org Chem. 2007 Mar 30;72(7):2485-93 - PubMed
  4. Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12305-10 - PubMed
  5. Org Lett. 2008 Oct 16;10(20):4529-32 - PubMed
  6. Org Lett. 2006 Oct 26;8(22):5149-52 - PubMed
  7. J Med Chem. 1986 Oct;29(10):1945-52 - PubMed
  8. J Biol Chem. 2000 Sep 8;275(36):27832-7 - PubMed
  9. Curr Opin Biotechnol. 2005 Dec;16(6):622-30 - PubMed
  10. Mol Interv. 2003 May;3(3):157-68 - PubMed
  11. N Engl J Med. 1982 Feb 25;306(8):484 - PubMed
  12. Org Lett. 2008 Jun 5;10(11):2283-6 - PubMed
  13. Mol Pharmacol. 1973 Jan;9(1):51-60 - PubMed
  14. Org Lett. 2002 May 16;4(10):1771-4 - PubMed
  15. J Med Chem. 1982 Oct;25(10):1222-6 - PubMed
  16. Eur J Biochem. 2004 Mar;271(5):1054-62 - PubMed
  17. J Org Chem. 2007 Apr 13;72(8):3125-8 - PubMed
  18. Lancet. 1979 Mar 10;1(8115):563 - PubMed
  19. J Med Chem. 1984 Mar;27(3):256-61 - PubMed
  20. J Am Chem Soc. 2003 Oct 15;125(41):12406-7 - PubMed
  21. J Nat Prod. 2005 Nov;68(11):1642-5 - PubMed
  22. ACS Med Chem Lett. 2010 Jul 12;1(7):326-330 - PubMed
  23. Mol Interv. 2008 Feb;8(1):36-49 - PubMed
  24. J Biol Chem. 2000 Sep 8;275(36):27838-44 - PubMed
  25. Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2610-5 - PubMed

Publication Types

Grant support